Tehran, April 22, IRNA - Iranian researchers have improved the delivery of anti-cancer doxorubicin (DOX) drug. Professor Davoud Habibi, a faculty member of Bu-Ali Sina University, Professor Mohammad Mostafapour-Amini, a faculty member of Shahid Beheshti University, and Sharif Kamyabi, a faculty member of Farhangian University and PhD student at ...